STOCK TITAN

Cronos Group Inc. to Hold 2024 First Quarter Earnings Conference Call on May 9, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Cronos Group Inc. will host its 2024 First Quarter Earnings Conference Call on May 9, 2024, where senior management will discuss financial results and take questions from investors.
Cronos Group Inc. ospiterà la teleconferenza sui risultati finanziari del primo trimestre 2024 il 9 maggio 2024, durante la quale il management senior discuterà i risultati finanziari e risponderà alle domande degli investitori.
Cronos Group Inc. llevará a cabo su Conferencia de Resultados del Primer Trimestre de 2024 el 9 de mayo de 2024, donde la alta dirección discutirá los resultados financieros y responderá preguntas de los inversores.
크로노스 그룹 인크가 2024년 5월 9일에 2024년도 제 1분기 실적 발표 컨퍼런스 콜을 개최할 예정이며, 고위 경영진이 재무 결과를 논의하고 투자자들의 질문에 답할 것입니다.
Cronos Group Inc. organisera sa conférence téléphonique sur les résultats du premier trimestre 2024 le 9 mai 2024, où la direction senior discutera des résultats financiers et répondra aux questions des investisseurs.
Die Cronos Group Inc. wird am 9. Mai 2024 ihren Ergebnisbericht zur Telefonkonferenz für das erste Quartal 2024 veranstalten, bei dem das Senior Management die Finanzergebnisse besprechen und Fragen von Investoren beantworten wird.
Positive
  • None.
Negative
  • None.

TORONTO, April 25, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 first quarter earnings conference call on Thursday, May 9, 2024 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.

To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be archived for replay on the Company’s website.

About Cronos
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

Forward-looking Statements
This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about Cronos’ intention to build an international iconic brand portfolio and develop disruptive intellectual property. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 which has been filed on SEDAR and EDGAR and can be accessed at www.sedar.com and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

Cronos Contact
Shayne Laidlaw
Investor Relations
Tel: (416) 504-0004
investor.relations@thecronosgroup.com


FAQ

When will Cronos Group Inc. host its 2024 First Quarter Earnings Conference Call?

Cronos Group Inc. will host its 2024 First Quarter Earnings Conference Call on May 9, 2024.

What time will the conference call take place?

The conference call will take place at 8:30 a.m. ET.

How can participants register for the conference call or webcast?

Participants can register online at https://ir.thecronosgroup.com/events-presentations.

Is there a recommended time for participants to dial into the conference call?

To avoid delays, participants should dial into the conference call fifteen minutes ahead of the scheduled start time.

Will the webcast of the call be available for replay?

Yes, the webcast of the call will be archived for replay on the Company's website.

Cronos Group Inc. Common Share

NASDAQ:CRON

CRON Rankings

CRON Latest News

CRON Stock Data

985.59M
203.49M
46.57%
13.1%
1.46%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States of America
TORONTO

About CRON

cronos group is a globally diversified and vertically integrated cannabis company with a presence across four continents. the company operates two wholly-owned canadian licensed producers regulated under health canada’s access to cannabis for medical purposes regulations: peace naturals project inc. (ontario), which was the first non-incumbent medical cannabis license granted by health canada, and original bc ltd. (british columbia), which is based in the okanagan valley. the company has multiple international production and distribution platforms: cronos israel and cronos australia. through an exclusive distribution agreement, cronos also has access to over 12,000 pharmacies in germany as the company focuses on building an international iconic brand portfolio and developing disruptive intellectual property.